Search

Your search keyword '"Gartner, Silvia"' showing total 122 results
Start Over Author "Gartner, Silvia" Search Limiters Full Text
122 results on '"Gartner, Silvia"'

1. Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis

Author

Southern, Kevin W., Castellani, Carlo, Lammertyn, Elise, Smyth, Alan, VanDevanter, Donald, van Koningsbruggen-Rietschel, Silke, Barben, Jürg, Bevan, Amanda, Brokaar, Edwin, Collins, Sarah, Connett, Gary J., Daniels, Thomas W.V., Davies, Jane, Declercq, Dimitri, Gartner, Silvia, Gramegna, Andrea, Hamilton, Naomi, Hauser, Jenny, Kashirskaya, Nataliya, Kessler, Laurence, Lowdon, Jacqueline, Makukh, Halyna, Martin, Clémence, Morrison, Lisa, Nazareth, Dilip, Noordhoek, Jacquelien, O'Neill, Ciaran, Owen, Elizabeth, Oxley, Helen, Raraigh, Karen S., Raynal, Caroline, Robinson, Karen, Roehmel, Jobst, Schwarz, Carsten, Sermet, Isabelle, Shteinberg, Michal, Sinha, Ian, Takawira, Constance, van Mourik, Peter, Verkleij, Marieke, Waller, Michael D., and Duff, Alistair

Published
2023
Full Text
View/download PDF

2. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

Author

Bell, Scott C, Reid, David, Wark, Peter, Van Braeckel, Eva, Gohy, Sophie, Knoop, Christiane, Pirson, Jessica, De Wachter, Elke, Dupont, Lieven, Hanssens, Laurence, Nowé, Vicky, Lequesne, Monique, Athanazio, Rodrigo A, Meneses, Daniela G, Boussaud, Véronique, Brinchault, Graziella, Coirier-Duet, Emmanuelle, Dubus, Jean-Christophe, Grenet, Dominique, de Miranda, Sandra, Beaumont, Laurence, Kanaan, Reem, Lauraens, Muriel, Martin, Clémence, Mittaine, Marie, Prévotat, Anne, Reynaud-Gaubert, Martine, Sermet-Gaudelus, Isabelle, Tatopoulos, Aurelie, Chiron, Raphael, Dalphin, Marie-Laure, Gerardin, Michele, Weiss, Laurence, Wizla, Nathalie, Ramel, Sophie, Plant, Barry, Gunaratnam, Cedric, Jackson, Abaigeal, de Winter- de Groot, Karin, Luijk, Bart, Wesseling, Geertjan, Kondratyeva, Elena, Zhekayte, Elena, Amelina, Elena, Mukhina, Mariya, Simonova, Olga, Alvarez-Fernandez, Antonio, Sole-Jover, Amparo, Cortell-Aznar, Isidoro, Girón-Moreno, Rosa, López-Neyra, Alejandro, Ramos-Cancelo, Isabel, Lázaro-Carrasco, Maite, Vivero, Dolores Pastor, de Valbuena, Marta Ruiz, Prados-Sanchez, Concepción, Costa-Colomer, Jordi, Gartner, Silvia, Diab-Caceres, Layla, Gilljam, Marita, Lindberg, Ulrika, Diemer, Stefanie, Allenby, Mark, Bourke, Stephen J, Charman, Susan C, Collinson, Janet, Dempsey, Owen, Denniston, Sarah, Desai, Maya, Duckers, Jamie, Etherington, Christine, Gunn, Elaine, Higton, Alex, Ho, Timothy, Hull, Jeremy, Jones, Andrew, Ketchell, Robert Ian, Madge, Susan L., Maitra, Anirban, Mujtaba, Ghulam, Nash, Edward, Nazareth, Dilip, O'Brien, Christopher, Onyon, Claire, Orchard, Christopher, Peckham, Daniel, Rodgers, Helen, Shafi, Nadia, Simmonds, Nicholas, Southern, Kevin, Walshaw, Martin, Watson, Danie, Whitehouse, Joanna L., Orenti, Annalisa, Elnazir, Basil, Cox, Des, Carr, Siobhán B, McClenaghan, Elliot, Elbert, Alexander, Faro, Albert, Cosgriff, Rebecca, Abdrakhmanov, Olzhas, Brownlee, Keith, Burgel, Pierre-Régis, Byrnes, Catherine A, Cheng, Stephanie Y, Colombo, Carla, Corvol, Harriet, Daneau, Géraldine, Goss, Christopher H, Gulmans, Vincent, Gutierrez, Hector, Harutyunyan, Satenik, Helmick, Meagan, Jung, Andreas, Kashirskaya, Nataliya, McKone, Edward, Melo, Joel, Middleton, Peter G, Mondejar-Lopez, Pedro, de Monestrol, Isabelle, Nährlich, Lutz, Padoan, Rita, Parker, Megan, Pastor-Vivero, M Dolores, Rizvi, Samar, Ruseckaite, Rasa, Salvatore, Marco, da Silva-Filho, Luiz Vicente R F, Versmessen, Nick, Zampoli, Marco, Marshall, Bruce C, and Stephenson, Anne L

Published
2022
Full Text
View/download PDF

3. Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation

Author

Mondejar-Lopez, Pedro, Zolin, Anna, Garcia-Marcos, Patricia W., Pastor-Vivero, Mª Dolores, Rosa-Silvestre, Maria, de Asis Sanchez-Martinez, Francisco, Salvatore, Donatello, Cimino, Giuseppe, Majo, Fabio, Sole-Jover, Amparo, Asensio de la Cruz, Oscar, Calderazzo, Maria Adelaide, Pizzamiglio, Giovanna, Castillo-Corullon, Silvia, Alvarez-Fernandez, Antonio, Gartner, Silvia, Padoan, Rita, Carnovale, Vincenzo, Salvatore, Marco, Moya-Quiles, Mª Rosa, Orenti, Annalisa, Glover, Guillermo, and Sanchez-Solis, Manuel

Published
2022
Full Text
View/download PDF

4. Incidence and Prevalence of Children's Diffuse Lung Disease in Spain

Author

Torrent-Vernetta, Alba, Gaboli, Mirella, Castillo-Corullón, Silvia, Mondéjar-López, Pedro, Sanz Santiago, Verónica, Costa-Colomer, Jordi, Osona, Borja, Torres-Borrego, Javier, de la Serna-Blázquez, Olga, Bellón Alonso, Sara, Caro Aguilera, Pilar, Gimeno-Díaz de Atauri, Álvaro, Valenzuela Soria, Alfredo, Ayats, Roser, Martin de Vicente, Carlos, Velasco González, Valle, Moure González, José Domingo, Canino Calderín, Elisa María, Pastor-Vivero, María Dolores, Villar Álvarez, María Ángeles, Rovira-Amigo, Sandra, Iglesias Serrano, Ignacio, Díez Izquierdo, Ana, de Mir Messa, Inés, Gartner, Silvia, Navarro, Alexandra, Baz-Redón, Noelia, Carmona, Rosario, Camats-Tarruella, Núria, Fernández-Cancio, Mónica, Rapp, Christina, Dopazo, Joaquin, Griese, Matthias, and Moreno-Galdó, Antonio

Published
2022
Full Text
View/download PDF

5. Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)

Author

Barben, Jürg, Castellani, Carlo, Munck, Anne, Davies, Jane C., de Winter–de Groot, Karin M., Gartner, Silvia, Kashirskaya, Nataliya, Linnane, Barry, Mayell, Sarah J, McColley, Susanna, Ooi, Chee Y., Proesmans, Marijke, Ren, Clement L., Salinas, Danieli, Sands, Dorota, Sermet-Gaudelus, Isabelle, Sommerburg, Olaf, and Southern, Kevin W

Published
2021
Full Text
View/download PDF

6. Implementation of a gene panel for genetic diagnosis of primary ciliary dyskinesia

Author

Baz-Redón, Noelia, Rovira-Amigo, Sandra, Paramonov, Ida, Castillo-Corullón, Silvia, Cols-Roig, Maria, Antolín, María, García-Arumí, Elena, Torrent-Vernetta, Alba, de Mir Messa, Inés, Gartner, Silvia, Iglesias-Serrano, Ignacio, Caballero-Rabasco, M. Araceli, Asensio de la Cruz, Óscar, Vizmanos-Lamotte, Gerardo, Martín de Vicente, Carlos, Martínez-Colls, María del Mar, Reula, Ana, Escribano, Amparo, Dasí, Francisco, Armengot-Carceller, Miguel, Polverino, Eva, Amengual Pieras, Esther, Amaro-Rodríguez, Rosanel, Garrido-Pontnou, Marta, Tizzano, Eduardo, Camats-Tarruella, Núria, Fernández-Cancio, Mónica, and Moreno-Galdó, Antonio

Published
2021
Full Text
View/download PDF

7. Implementación de un panel de genes para el diagnóstico genético de la discinesia ciliar primaria

Author

Baz-Redón, Noelia, Rovira-Amigo, Sandra, Paramonov, Ida, Castillo-Corullón, Silvia, Cols Roig, Maria, Antolín, María, García Arumí, Elena, Torrent-Vernetta, Alba, de Mir Messa, Inés, Gartner, Silvia, Iglesias Serrano, Ignacio, Caballero-Rabasco, M. Araceli, Asensio de la Cruz, Óscar, Vizmanos-Lamotte, Gerardo, Martín de Vicente, Carlos, Martínez-Colls, María del Mar, Reula, Ana, Escribano, Amparo, Dasí, Francisco, Armengot-Carceller, Miguel, Polverino, Eva, Amengual Pieras, Esther, Amaro-Rodríguez, Rosanel, Garrido-Pontnou, Marta, Tizzano, Eduardo, Camats-Tarruella, Núria, Fernández-Cancio, Mónica, and Moreno-Galdó, Antonio

Published
2021
Full Text
View/download PDF

8. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

Author

Aguilar-Fernández, Antonio J., Andres-Martin, Anselmo, Blanco-Aparicio, Marina, Sirvent-Gomez, Josep, Barajas-Sanchez, Verisima, Baranda, Felix, Gomez-Bonilla, Ainhoa, Bousoño-Garcia, Carlos, Garcia-Clemente, Marta, Bover-Bauza, Catalina, Figuerola-Mulet, Joan, Cabero-Perez, M. Jesús, Iturbe-Fernandez, David, Carrasco-Hernandez, Laura, Delgado-Pecellin, Isabel, Casas-Maldonado, Francisco, Merlos-Navarro, Silvia, Valenzuela-Soria, Alfredo, Cascante-Rodrigo, J. Antonio, Moreno-Galarraga, Laura, Cols-Roig, Maria, de la Cruz, Ofelia Fernandez, Gomez de Terreros, Francisco J., Garcia-Magan, Carlos, Gartner, Silvia, Gomez-Pastrana, David, Gonzalez-Castro, Estela, Jimenez-Nogueira, Esperanza, Herrero-Labarga, M. Ines, de Vicente, Carlos Martín, Juste-Ruiz, Mercedes, Lamas-Ferreiro, Adelaida, Maiz-Carro, Luis, Luna-Paredes, M. Carmen, Mesa-Medina, Orlando, Monton-Soler, Concepcion, Ramos-Hernandez, Cristina, Rodriguez-Saez, M. Jesus, Romero-Albillos, J. Alejandro, Sanz-Santiago, Veronica, Villa-Asensi, J. Ramón, Torres-Borrego, Javier, Vaquero-Barrios, J. Manuel, Velasco-Bernardo, Rosa, Velasco-Gonzalez, Valle, Mondejar-Lopez, Pedro, Quintana-Gallego, Esther, Giron-Moreno, Rosa M., Cortell-Aznar, Isidoro, Ruiz de Valbuena-Maiz, Marta, Diab-Caceres, Layla, Prados-Sanchez, Concepcion, Alvarez-Fernandez, Antonio, Garcia-Marcos, Patricia W., Peñalver-Mellado, Carlos, Pastor-Vivero, M. Dolores, Olveira, Casilda, Lopez-Neyra, Alejandro, Castillo-Corullon, Silvia, Palma-Milla, Samara, Perez-Ruiz, Estela, Sole-Jover, Amparo, Barrio, M. Isabel, Sanchez-Solis, Manuel, and Asensio de la Cruz, Óscar

Published
2020
Full Text
View/download PDF

9. Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis

Author

Renner, Sabine, Knoop, Christiane, Malfroot, Anne, Dupont, Lieven, Desager, Kristine, De Baets, Frans, Bosheva, Miroslava, Nedkova, Vania, Galabov, Ivan, Galeva, Ivanka, Freitag, Andreas, Morrison, Nancy, Wilcox, Pearce, Pressler, Tanja, Martinet, Yves, Chiron, Raphael, Fajac, Isabelle, Dominique, Stephan, Reix, Philippe, Prevotat, Anne, Sermet, Isabelle, Durieu, Isabelle, Fischer, Rainald, Huber, Rudolf, Staab, Doris, Mellies, Uwe, Sextro, Wolfgang, Welte, Tobias, Wilkens, Heinrike, Sommerwerk, Urte, Bewig, Burkhard, Inglezos, Ilias, Doudounakis, Stavros-Eleftherios, Bede, Olga, Gönczi, Ferenc, Újhelyi, Rita, McKone, Edward, McNally, Paul, Lucidi, Vincenzina, Cipolli, Marco, La Rosa, Mario, Minicucci, Laura, Padoan, Rita, Pisi, Giovanna, Gagliardini, Rolando, Colombo, Carla, Bronsveld, Inez, Sapiejka, Ewa, Mazurek, Henryk, Sands, Dorota, Górnicka, Grażyna, Stelmach, Iwona, Batura-Gabryel, Halina, Rachel, Marta, Minic, Predrag, Orosova, Jaroslava, Takac, Branko, Feketova, Anna, Martinez, Carmen, Hernandez, Gloria Garcia, Villa-Asensi, Jose Ramon, Gartner, Silvia, Sole, Amparo, Lindblad, Anders, Ledson, Martin, Bilton, Diana, Whitehouse, Joanna, Smyth, Alan, Ketchell, Ian, Lee, Timothy, MacGregor, Gordon, Pressler, Tacjana, Clancy, John Paul, Solé, Amparo, Quittner, Alexandra L., Liu, Keith, McGinnis, John P., II, Eagle, Gina, Gupta, Renu, and Konstan, Michael W.

Published
2020
Full Text
View/download PDF

11. Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues

Author

MMB, Infection & Immunity, Burgel, Pierre Régis, Southern, Kevin W., Addy, Charlotte, Battezzati, Alberto, Berry, Claire, Bouchara, Jean Philippe, Brokaar, Edwin, Brown, Whitney, Azevedo, Pilar, Durieu, Isabelle, Ekkelenkamp, Miquel, Finlayson, Felicity, Forton, Julian, Gardecki, Johanna, Hodkova, Pavla, Hong, Gina, Lowdon, Jacqueline, Madge, Su, Martin, Clémence, McKone, Edward, Munck, Anne, Ooi, Chee Y., Perrem, Lucy, Piper, Amanda, Prayle, Andrew, Ratjen, Felix, Rosenfeld, Margaret, Sanders, Don B., Schwarz, Carsten, Taccetti, Giovanni, Wainwright, Claire, West, Natalie E., Wilschanski, Michael, Bevan, Amanda, Castellani, Carlo, Drevinek, Pavel, Gartner, Silvia, Gramegna, Andrea, Lammertyn, Elise, Landau, Eddie (Edwina) C., Plant, Barry J., Smyth, Alan R., van Koningsbruggen-Rietschel, Silke, Middleton, Peter G., MMB, Infection & Immunity, Burgel, Pierre Régis, Southern, Kevin W., Addy, Charlotte, Battezzati, Alberto, Berry, Claire, Bouchara, Jean Philippe, Brokaar, Edwin, Brown, Whitney, Azevedo, Pilar, Durieu, Isabelle, Ekkelenkamp, Miquel, Finlayson, Felicity, Forton, Julian, Gardecki, Johanna, Hodkova, Pavla, Hong, Gina, Lowdon, Jacqueline, Madge, Su, Martin, Clémence, McKone, Edward, Munck, Anne, Ooi, Chee Y., Perrem, Lucy, Piper, Amanda, Prayle, Andrew, Ratjen, Felix, Rosenfeld, Margaret, Sanders, Don B., Schwarz, Carsten, Taccetti, Giovanni, Wainwright, Claire, West, Natalie E., Wilschanski, Michael, Bevan, Amanda, Castellani, Carlo, Drevinek, Pavel, Gartner, Silvia, Gramegna, Andrea, Lammertyn, Elise, Landau, Eddie (Edwina) C., Plant, Barry J., Smyth, Alan R., van Koningsbruggen-Rietschel, Silke, and Middleton, Peter G.

Published
2024

12. ALPINE2:Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosis

Author

Gilchrist, Francis J., Bui, Stephanie, Gartner, Silvia, McColley, Susanna A., Tiddens, Harm, Ruiz, Gary, Stehling, Florian, Alani, Muhsen, Gurtovaya, Oksana, Bresnik, Mark, Watkins, Timothy R., Frankovic, Biliana, Skov, Marianne, Gilchrist, Francis J., Bui, Stephanie, Gartner, Silvia, McColley, Susanna A., Tiddens, Harm, Ruiz, Gary, Stehling, Florian, Alani, Muhsen, Gurtovaya, Oksana, Bresnik, Mark, Watkins, Timothy R., Frankovic, Biliana, and Skov, Marianne

Abstract

Background: Antibiotic eradication therapies recommended for newly isolated Pseudomonas aeruginosa (Pa) in people with cystic fibrosis (pwCF) can be burdensome. ALPINE2 compared the efficacy and safety of a shortened 14-day course of aztreonam for inhalation solution (AZLI) with 28-day AZLI in paediatric pwCF. Methods: ALPINE2 (a double-blind, phase 3b study) included children aged 3 months to <18 years with CF and new-onset Pa infection. Participants were randomized to receive 75 mg AZLI three times daily for either 28 or 14 days followed by 14 days' matched placebo. The primary endpoint was rate of primary Pa eradication (no Pa detected during the 4 weeks post AZLI treatment). Non-inferiority was achieved if the lower 95% CI bound of the treatment difference between the two arms was above −20%. Secondary endpoints included assessments of Pa recurrence during 108 weeks of follow-up after primary eradication. Safety endpoints included treatment-emergent adverse events (TEAEs). Results: In total, 149 participants were randomized (14-day AZLI, n = 74; 28-day AZLI, n = 75) and 142 (95.3%) completed treatment. Median age: 6.0 years (range: 0.3–17.0). Baseline characteristics were similar between treatment arms. Primary Pa eradication rates: 14-day AZLI, 55.9%; 28-day AZLI, 63.4%; treatment difference (CI), −8.0% (−24.6, 8.6%). Pa recurrence rates at follow-up end: 14-day AZLI, 54.1% (n = 20/37); 28-day AZLI, 41.9% (n = 18/43). TEAEs were similar between treatment arms. No new safety signals were observed. Conclusions: Non-inferiority of 14-day AZLI versus 28-day AZLI was not demonstrated. Both courses were well tolerated, further supporting AZLI short-term safety in paediatric and adolescent pwCF. ClinicalTrials.gov

Published
2024

13. Standards for the care of people with cystic fibrosis; establishing and maintaining health

Author

Southern, Kevin W; https://orcid.org/0000-0001-6516-9083, Addy, Charlotte, Bell, Scott C; https://orcid.org/0000-0001-8651-7139, Bevan, Amanda, Borawska, Urzula, Brown, Catherine, Burgel, Pierre-Régis, Button, Brenda, Castellani, Carlo, Chansard, Audrey, Chilvers, Mark, Davies, Gwyneth, Davies, Jane C, De Boeck, Kris, Declercq, Dimitri, Doumit, Michael, Drevinek, Pavel, Fajac, Isabelle, Gartner, Silvia, Georgiopoulos, Anna M, Gursli, Sandra, Gramegna, Andrea, Hansen, Carina M E, Hug, Martin J, Lammertyn, Elise, Landau, Edwina (Eddie) C, Langley, Ross, Mayer-Hamblett, Nicole, Middleton, Anna, Middleton, Peter G, Radtke, Thomas; https://orcid.org/0000-0002-1723-1070, et al, Southern, Kevin W; https://orcid.org/0000-0001-6516-9083, Addy, Charlotte, Bell, Scott C; https://orcid.org/0000-0001-8651-7139, Bevan, Amanda, Borawska, Urzula, Brown, Catherine, Burgel, Pierre-Régis, Button, Brenda, Castellani, Carlo, Chansard, Audrey, Chilvers, Mark, Davies, Gwyneth, Davies, Jane C, De Boeck, Kris, Declercq, Dimitri, Doumit, Michael, Drevinek, Pavel, Fajac, Isabelle, Gartner, Silvia, Georgiopoulos, Anna M, Gursli, Sandra, Gramegna, Andrea, Hansen, Carina M E, Hug, Martin J, Lammertyn, Elise, Landau, Edwina (Eddie) C, Langley, Ross, Mayer-Hamblett, Nicole, Middleton, Anna, Middleton, Peter G, Radtke, Thomas; https://orcid.org/0000-0002-1723-1070, and et al

Published
2024

17. Cystic Fibrosis Cases Missed by Newborn Bloodspot Screening—Towards a Consistent Definition and Data Acquisition

Author

Munck, Anne, primary, Southern, Kevin W., additional, Murphy, Jared, additional, de Winter-de Groot, Karin M., additional, Gartner, Silvia, additional, Karadag, Bülent, additional, Kashirskaya, Nataliya, additional, Linnane, Barry, additional, Proesmans, Marijke, additional, Sands, Dorota, additional, Sommerburg, Olaf, additional, Castellani, Carlo, additional, and Barben, Jürg, additional

Published
2023
Full Text
View/download PDF

19. Elevated Prostaglandin E 2 Synthesis Is Associated with Clinical and Radiological Disease Severity in Cystic Fibrosis.

Author

Gartner, Silvia, Roca-Ferrer, Jordi, Fernandez-Alvarez, Paula, Lima, Isabel, Rovira-Amigo, Sandra, García-Arumi, Elena, Tizzano, Eduardo F., and Picado, César

Subjects
*CYSTIC fibrosis, *PROSTAGLANDINS, *TANDEM mass spectrometry, *GENETIC polymorphisms, *BRONCHIECTASIS, *LIQUID chromatography
Abstract

Background: Previous studies found high but very variable levels of tetranor-PGEM and PGDM (urine metabolites of prostaglandin (PG) E2 and PGD2, respectively) in persons with cystic fibrosis (pwCF). This study aims to assess the role of cyclooxygenase COX-1 and COX-2 genetic polymorphisms in PG production and of PG metabolites as potential markers of symptoms' severity and imaging findings. Methods: A total of 30 healthy subjects and 103 pwCF were included in this study. Clinical and radiological CF severity was evaluated using clinical scoring methods and chest computed tomography (CT), respectively. Urine metabolites were measured using liquid chromatography/tandem mass spectrometry. Variants in the COX-1 gene (PTGS1 639 C>A, PTGS1 762+14delA and COX-2 gene: PTGS2-899G>C (-765G>C) and PTGS2 (8473T>C) were also analyzed. Results: PGE-M and PGD-M urine concentrations were significantly higher in pwCF than in controls. There were also statistically significant differences between clinically mild and moderate disease and severe disease. Patients with bronchiectasis and/or air trapping had higher PGE-M levels than patients without these complications. The four polymorphisms did not associate with clinical severity, air trapping, bronchiectasis, or urinary PG levels. Conclusions: These results suggest that urinary PG level testing can be used as a biomarker of CF severity. COX genetic polymorphisms are not involved in the variability of PG production. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

22. Incidence and Prevalence of Children's Diffuse Lung Disease in Spain

Author

Sociedad Española de Neumología Pediátrica, European Commission, Sociedad Española de Neumología y Cirugía Torácica, Instituto de Salud Carlos III, Torrent-Vernetta, Alba [0000-0002-3575-2427], Gaboli, Mirella [0000-0002-1600-0916], Castillo-Corullón, Silvia [0000-0002-0121-2676], Mondéjar-López, Pedro [0000-0003-0145-0583], Sanz Santiago, Verónica [0000-0003-3368-8393], Costa-Colomer, Jordi [0000-0001-5530-2661], Osona, Borja [0000-0001-6337-0269], Bellón Alonso, Sara [0000-0001-9917-6919], Caro Aguilera, Pilar [0000-0003-2807-1153], Gimeno-Díaz de Atauri, Álvaro [0000-0003-4775-892X], Ayats, Roser [0000-0002-5245-9847], Canino Calderín, Elisa María0000-0002-6452-7843, Pastor, María Dolores [0000-0001-8917-4709], Rovira-Amigo, Sandra [0000-0001-9896-0621], Iglesias Serrano, Ignacio [0000-0002-2171-7508], Díez Izquierdo, Ana [0000-0002-0471-2991], Mir Messa, Inés de [0000-0002-1418-4563], Gartner, Silvia [0000-0002-8190-5092], Baz-Redón, Noelia [0000-0003-1704-3413], Carmona, Rosario [0000-0002-4235-2886], Camats-Tarruella, Núria [0000-0002-4863-8201], Fernández-Cancio, Mónica [0000-0003-1872-3488], Rapp, Christina [0000-0002-7371-8158], Dopazo, Joaquín [0000-0003-3318-120X], Griese, Matthias [0000-0003-0113-912X], Moreno-Galdó, Antonio [0000-0002-2496-9786], Torrent-Vernetta, Alba, Gaboli, Mirella, Castillo-Corullón, Silvia, Mondéjar-López, Pedro, Sanz Santiago, Verónica, Costa-Colomer, Jordi, Osona, Borja, Torres-Borrego, Javier, Serna-Blázquez, Olga de la, Bellón Alonso, Sara, Caro Aguilera, Pilar, Gimeno-Díaz de Atauri, Álvaro, Valenzuela Soria, Alfredo, Ayats, Roser, Martín de Vicente, Carlos, Velasco González, Valle, Moure González, José Domingo, Canino Calderín, Elisa María, Pastor, María Dolores, Villar Álvarez, María Ángeles, Rovira-Amigo, Sandra, Iglesias Serrano, Ignacio, Díez Izquierdo, Ana, Mir Messa, Inés de, Gartner, Silvia, Navarro, Alexandra, Baz-Redón, Noelia, Carmona, Rosario, Camats-Tarruella, Núria, Fernández-Cancio, Mónica, Rapp, Christina, Dopazo, Joaquín, Griese, Matthias, Moreno-Galdó, Antonio, Sociedad Española de Neumología Pediátrica, European Commission, Sociedad Española de Neumología y Cirugía Torácica, Instituto de Salud Carlos III, Torrent-Vernetta, Alba [0000-0002-3575-2427], Gaboli, Mirella [0000-0002-1600-0916], Castillo-Corullón, Silvia [0000-0002-0121-2676], Mondéjar-López, Pedro [0000-0003-0145-0583], Sanz Santiago, Verónica [0000-0003-3368-8393], Costa-Colomer, Jordi [0000-0001-5530-2661], Osona, Borja [0000-0001-6337-0269], Bellón Alonso, Sara [0000-0001-9917-6919], Caro Aguilera, Pilar [0000-0003-2807-1153], Gimeno-Díaz de Atauri, Álvaro [0000-0003-4775-892X], Ayats, Roser [0000-0002-5245-9847], Canino Calderín, Elisa María0000-0002-6452-7843, Pastor, María Dolores [0000-0001-8917-4709], Rovira-Amigo, Sandra [0000-0001-9896-0621], Iglesias Serrano, Ignacio [0000-0002-2171-7508], Díez Izquierdo, Ana [0000-0002-0471-2991], Mir Messa, Inés de [0000-0002-1418-4563], Gartner, Silvia [0000-0002-8190-5092], Baz-Redón, Noelia [0000-0003-1704-3413], Carmona, Rosario [0000-0002-4235-2886], Camats-Tarruella, Núria [0000-0002-4863-8201], Fernández-Cancio, Mónica [0000-0003-1872-3488], Rapp, Christina [0000-0002-7371-8158], Dopazo, Joaquín [0000-0003-3318-120X], Griese, Matthias [0000-0003-0113-912X], Moreno-Galdó, Antonio [0000-0002-2496-9786], Torrent-Vernetta, Alba, Gaboli, Mirella, Castillo-Corullón, Silvia, Mondéjar-López, Pedro, Sanz Santiago, Verónica, Costa-Colomer, Jordi, Osona, Borja, Torres-Borrego, Javier, Serna-Blázquez, Olga de la, Bellón Alonso, Sara, Caro Aguilera, Pilar, Gimeno-Díaz de Atauri, Álvaro, Valenzuela Soria, Alfredo, Ayats, Roser, Martín de Vicente, Carlos, Velasco González, Valle, Moure González, José Domingo, Canino Calderín, Elisa María, Pastor, María Dolores, Villar Álvarez, María Ángeles, Rovira-Amigo, Sandra, Iglesias Serrano, Ignacio, Díez Izquierdo, Ana, Mir Messa, Inés de, Gartner, Silvia, Navarro, Alexandra, Baz-Redón, Noelia, Carmona, Rosario, Camats-Tarruella, Núria, Fernández-Cancio, Mónica, Rapp, Christina, Dopazo, Joaquín, Griese, Matthias, and Moreno-Galdó, Antonio

Abstract

[Background] Children's diffuse lung disease, also known as children's Interstitial Lung Diseases (chILD), are a heterogeneous group of rare diseases with relevant morbidity and mortality, which diagnosis and classification are very complex. Epidemiological data are scarce. The aim of this study was to analyse incidence and prevalence of chILD in Spain., [Methods] Multicentre observational prospective study in patients from 0 to 18 years of age with chILD to analyse its incidence and prevalence in Spain, based on data reported in 2018 and 2019., [Results] A total of 381 cases with chILD were notified from 51 paediatric pulmonology units all over Spain, covering the 91.7% of the paediatric population. The average incidence of chILD was 8.18 (CI 95% 6.28–10.48) new cases/million of children per year. The average prevalence of chILD was 46.53 (CI 95% 41.81–51.62) cases/million of children. The age group with the highest prevalence were children under 1 year of age. Different types of disorders were seen in children 2–18 years of age compared with children 0–2 years of age. Most frequent cases were: primary pulmonary interstitial glycogenosis in neonates (17/65), neuroendocrine cell hyperplasia of infancy in infants from 1 to 12 months (44/144), idiopathic pulmonary haemosiderosis in children from 1 to 5 years old (13/74), hypersensitivity pneumonitis in children from 5 to 10 years old (9/51), and scleroderma in older than 10 years old (8/47)., [Conclusions] We found a higher incidence and prevalence of chILD than previously described probably due to greater understanding and increased clinician awareness of these rare diseases., [Antecedentes] Las neumopatías intersticiales pediátricas, también conocidas con el acrónimo chILD (del inglés children's Interstitial Lung Diseases), es un grupo heterogéneo de enfermedades raras con morbimortalidad relevante, cuyo diagnóstico y clasificación son complejos. Los estudios epidemiológicos son escasos. El objetivo de este trabajo fue analizar la incidencia y la prevalencia de chILD en España., [Métodos] Estudio prospectivo observacional multicéntrico en pacientes de 0 a 18 años afectos de chILD para analizar la incidencia y la prevalencia en España, a partir de datos recogidos en 2018 y 2019., [Resultados] Se recogieron 381 casos de chILD entre 51 unidades de neumología pediátrica de toda España, que cubrían el 91,7% de la población pediátrica. La incidencia promedio fue 8,18 (IC 95%: 6,28-10,48) casos nuevos/millón de niños por año. La prevalencia promedio fue de 46,53 (IC 95%: 41,81-51,62) casos/millón de niños. El grupo de edad con mayor prevalencia fue el de niños menores de un año. Se observaron diferentes entidades en niños de 2 a 18 años en comparación con niños de 0 a 2 años. Los diagnósticos más frecuentes fueron: glucogenosis intersticial pulmonar primaria en neonatos (17/65), hiperplasia de células neuroendocrinas en lactantes de uno a 12 meses (44/144), hemosiderosis pulmonar idiopática en niños de uno a 5 años (13/74), neumonía por hipersensibilidad en niños de 5 a 10 años (9/51) y esclerodermia en mayores de 10 años (8/47)., [Conclusiones] Encontramos una mayor incidencia y prevalencia de chILD que las descritas previamente, probablemente debido a un mayor conocimiento y detección de estas enfermedades raras.

Published
2022

23. European survey of newborn bloodspot screening for CF: opportunity to address challenges and improve performance

Author

Longziekten patientenzorg, Child Health, Munck, Anne, Berger, Daria O, Southern, Kevin W, Carducci, Carla, de Winter-de Groot, Karin M, Gartner, Silvia, Kashirskaya, Nataliya, Linnane, Barry, Proesmans, Marijke, Sands, Dorota, Sommerburg, Olaf, Castellani, Carlo, Barben, Jürg, European CF Society Neonatal Screening Working Group (ECFS NSWG), Longziekten patientenzorg, Child Health, Munck, Anne, Berger, Daria O, Southern, Kevin W, Carducci, Carla, de Winter-de Groot, Karin M, Gartner, Silvia, Kashirskaya, Nataliya, Linnane, Barry, Proesmans, Marijke, Sands, Dorota, Sommerburg, Olaf, Castellani, Carlo, Barben, Jürg, and European CF Society Neonatal Screening Working Group (ECFS NSWG)

Published
2023

24. Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis

Author

Arts Assistenten Longziekten, Southern, Kevin W., Castellani, Carlo, Lammertyn, Elise, Smyth, Alan, VanDevanter, Donald, van Koningsbruggen-Rietschel, Silke, Barben, Jürg, Bevan, Amanda, Brokaar, Edwin, Collins, Sarah, Connett, Gary J., Daniels, Thomas W.V., Davies, Jane, Declercq, Dimitri, Gartner, Silvia, Gramegna, Andrea, Hamilton, Naomi, Hauser, Jenny, Kashirskaya, Nataliya, Kessler, Laurence, Lowdon, Jacqueline, Makukh, Halyna, Martin, Clémence, Morrison, Lisa, Nazareth, Dilip, Noordhoek, Jacquelien, O'Neill, Ciaran, Owen, Elizabeth, Oxley, Helen, Raraigh, Karen S., Raynal, Caroline, Robinson, Karen, Roehmel, Jobst, Schwarz, Carsten, Sermet, Isabelle, Shteinberg, Michal, Sinha, Ian, Takawira, Constance, van Mourik, Peter, Verkleij, Marieke, Waller, Michael D., Duff, Alistair, Arts Assistenten Longziekten, Southern, Kevin W., Castellani, Carlo, Lammertyn, Elise, Smyth, Alan, VanDevanter, Donald, van Koningsbruggen-Rietschel, Silke, Barben, Jürg, Bevan, Amanda, Brokaar, Edwin, Collins, Sarah, Connett, Gary J., Daniels, Thomas W.V., Davies, Jane, Declercq, Dimitri, Gartner, Silvia, Gramegna, Andrea, Hamilton, Naomi, Hauser, Jenny, Kashirskaya, Nataliya, Kessler, Laurence, Lowdon, Jacqueline, Makukh, Halyna, Martin, Clémence, Morrison, Lisa, Nazareth, Dilip, Noordhoek, Jacquelien, O'Neill, Ciaran, Owen, Elizabeth, Oxley, Helen, Raraigh, Karen S., Raynal, Caroline, Robinson, Karen, Roehmel, Jobst, Schwarz, Carsten, Sermet, Isabelle, Shteinberg, Michal, Sinha, Ian, Takawira, Constance, van Mourik, Peter, Verkleij, Marieke, Waller, Michael D., and Duff, Alistair

Published
2023

25. Follow-up protocol of patients with cystic fibrosis diagnosed by newborn screening

Author

Gartner, Silvia, Mondéjar-López, Pedro, Asensio de la Cruz, Óscar, Alonso, María José, Álvarez, Marina, Martín, Anselmo Andrés, Gómez de Agüero, María Isabel Barrio, Cabero Pérez, María Jesús, Caro Aguilera, Pilar, Cols Roig, María, Aznar-Pérez, Isidoro Cortell, Colomer, Jordi Costa, Delgado Pecellín, Isabel, Escribano Montaner, Amparo, Mulet, Joan Figuerola, Hernández, Gloria García, Guayarte, Pilar, Ortega, David Gil, Pastrana, David Gómez, Ferreiro, Adelaida Lamas, Marín Soria, José Luis, Martín de Vicente, Carlos, Merino, Martín Navarro, Oliva Hernández, Concepción, Pérez Frías, Javier, Pérez Ruiz, Estela, Rovira Amigo, Sandra, Salcedo Posadas, Antonio, Sánchez-Solís, Manuel, Sirvent Gómez, Josep, Vázquez Cordero, Carlos, and Villa Asensi, José Ramón

Published
2019
Full Text
View/download PDF

27. The Management of Asymptomatic Congenital Pulmonary Airway Malformation: Results of a European Delphi Survey

Author

Kersten, Casper M., primary, Hermelijn, Sergei M., additional, Mullassery, Dhanya, additional, Muthialu, Nagarajan, additional, Cobanoglu, Nazan, additional, Gartner, Silvia, additional, Bagolan, Pietro, additional, Mesas Burgos, Carmen, additional, Sgrò, Alberto, additional, Heyman, Stijn, additional, Till, Holger, additional, Suominen, Janne, additional, Schurink, Maarten, additional, Desender, Liesbeth, additional, Losty, Paul, additional, Steyaert, Henri, additional, Terheggen-Lagro, Suzanne, additional, Metzelder, Martin, additional, Bonnard, Arnaud, additional, Sfeir, Rony, additional, Singh, Michael, additional, Yardley, Iain, additional, Rikkers-Mutsaerts, Noor R. V. M., additional, van der Ent, Cornelis K., additional, Qvist, Niels, additional, Cox, Des W., additional, Peters, Robert, additional, Bannier, Michiel A. G. E., additional, Wessel, Lucas, additional, Proesmans, Marijke, additional, Stanton, Michael, additional, Hannon, Edward, additional, Zampoli, Marco, additional, Morini, Francesco, additional, Tiddens, Harm A. W. M., additional, Wijnen, René M. H., additional, and Schnater, Johannes M., additional

Published
2022
Full Text
View/download PDF

28. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

Author

Carr, Siobhán B, primary, McClenaghan, Elliot, additional, Elbert, Alexander, additional, Faro, Albert, additional, Cosgriff, Rebecca, additional, Abdrakhmanov, Olzhas, additional, Brownlee, Keith, additional, Burgel, Pierre-Régis, additional, Byrnes, Catherine A, additional, Cheng, Stephanie Y, additional, Colombo, Carla, additional, Corvol, Harriet, additional, Daneau, Géraldine, additional, Goss, Christopher H, additional, Gulmans, Vincent, additional, Gutierrez, Hector, additional, Harutyunyan, Satenik, additional, Helmick, Meagan, additional, Jung, Andreas, additional, Kashirskaya, Nataliya, additional, McKone, Edward, additional, Melo, Joel, additional, Middleton, Peter G, additional, Mondejar-Lopez, Pedro, additional, de Monestrol, Isabelle, additional, Nährlich, Lutz, additional, Padoan, Rita, additional, Parker, Megan, additional, Pastor-Vivero, M Dolores, additional, Rizvi, Samar, additional, Ruseckaite, Rasa, additional, Salvatore, Marco, additional, da Silva-Filho, Luiz Vicente R F, additional, Versmessen, Nick, additional, Zampoli, Marco, additional, Marshall, Bruce C, additional, Stephenson, Anne L, additional, Bell, Scott C, additional, Reid, David, additional, Wark, Peter, additional, Van Braeckel, Eva, additional, Gohy, Sophie, additional, Knoop, Christiane, additional, Pirson, Jessica, additional, De Wachter, Elke, additional, Dupont, Lieven, additional, Hanssens, Laurence, additional, Nowé, Vicky, additional, Lequesne, Monique, additional, Athanazio, Rodrigo A, additional, Meneses, Daniela G, additional, Boussaud, Véronique, additional, Brinchault, Graziella, additional, Coirier-Duet, Emmanuelle, additional, Dubus, Jean-Christophe, additional, Grenet, Dominique, additional, de Miranda, Sandra, additional, Beaumont, Laurence, additional, Kanaan, Reem, additional, Lauraens, Muriel, additional, Martin, Clémence, additional, Mittaine, Marie, additional, Prévotat, Anne, additional, Reynaud-Gaubert, Martine, additional, Sermet-Gaudelus, Isabelle, additional, Tatopoulos, Aurelie, additional, Chiron, Raphael, additional, Dalphin, Marie-Laure, additional, Gerardin, Michele, additional, Weiss, Laurence, additional, Wizla, Nathalie, additional, Ramel, Sophie, additional, Plant, Barry, additional, Gunaratnam, Cedric, additional, Jackson, Abaigeal, additional, de Winter- de Groot, Karin, additional, Luijk, Bart, additional, Wesseling, Geertjan, additional, Kondratyeva, Elena, additional, Zhekayte, Elena, additional, Amelina, Elena, additional, Mukhina, Mariya, additional, Simonova, Olga, additional, Alvarez-Fernandez, Antonio, additional, Sole-Jover, Amparo, additional, Cortell-Aznar, Isidoro, additional, Girón-Moreno, Rosa, additional, López-Neyra, Alejandro, additional, Ramos-Cancelo, Isabel, additional, Lázaro-Carrasco, Maite, additional, Vivero, Dolores Pastor, additional, de Valbuena, Marta Ruiz, additional, Prados-Sanchez, Concepción, additional, Costa-Colomer, Jordi, additional, Gartner, Silvia, additional, Diab-Caceres, Layla, additional, Gilljam, Marita, additional, Lindberg, Ulrika, additional, Diemer, Stefanie, additional, Allenby, Mark, additional, Bourke, Stephen J, additional, Charman, Susan C, additional, Collinson, Janet, additional, Dempsey, Owen, additional, Denniston, Sarah, additional, Desai, Maya, additional, Duckers, Jamie, additional, Etherington, Christine, additional, Gunn, Elaine, additional, Higton, Alex, additional, Ho, Timothy, additional, Hull, Jeremy, additional, Jones, Andrew, additional, Ketchell, Robert Ian, additional, Madge, Susan L., additional, Maitra, Anirban, additional, Mujtaba, Ghulam, additional, Nash, Edward, additional, Nazareth, Dilip, additional, O'Brien, Christopher, additional, Onyon, Claire, additional, Orchard, Christopher, additional, Peckham, Daniel, additional, Rodgers, Helen, additional, Shafi, Nadia, additional, Simmonds, Nicholas, additional, Southern, Kevin, additional, Walshaw, Martin, additional, Watson, Danie, additional, Whitehouse, Joanna L., additional, Orenti, Annalisa, additional, Elnazir, Basil, additional, and Cox, Des, additional

Published
2022
Full Text
View/download PDF

29. The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis (SHIP-CT):a multicentre, randomised, double-blind, controlled trial

Author

Tiddens, Harm A.W.M., Chen, Yuxin, Andrinopoulou, Eleni Rosalina, Davis, Stephanie D., Rosenfeld, Margaret, Ratjen, Felix, Kronmal, Richard A., Hinckley Stukovsky, Karen D., Dasiewicz, Alison, Stick, Stephen Michael, Anthony, Margaret M., Au, Jacky, Belessis, Yvonne, Bonte, Merlijn, Cheney, Joyce, Clem, Charles, Clements, Barry, Cooper, Peter, Davis, Miriam, de Boeck, Kris, de Marchis, Matteo, De Wachter, Elke, Delaisi, Bertrand, Delaup, Véronique, DeRicco, Adrienne, Foti, Alexia, Gan, Richard, Garriga, Laura, Gartner, Silvia, Genatossio, Alan, Grogan, Sam, Hilton, Jodi, Hoppe, Jordana E., Janssens, Hettie M., Jensen, Renee, Johnson, Robin, Kemner-van de Corput, Mariette P.C., Klein, Brendan, Lucca, Francesca, Lucidi, Vincencina, Montemitro, Enza, Nahidi, Lily, Nielsen, Kim G., Pearce, Kasey, Pittman, Jessica E., Powers, Michael, Sandvik, Rikke Mulvad, Smith, Julie, Tiddens, Harm A.W.M., Chen, Yuxin, Andrinopoulou, Eleni Rosalina, Davis, Stephanie D., Rosenfeld, Margaret, Ratjen, Felix, Kronmal, Richard A., Hinckley Stukovsky, Karen D., Dasiewicz, Alison, Stick, Stephen Michael, Anthony, Margaret M., Au, Jacky, Belessis, Yvonne, Bonte, Merlijn, Cheney, Joyce, Clem, Charles, Clements, Barry, Cooper, Peter, Davis, Miriam, de Boeck, Kris, de Marchis, Matteo, De Wachter, Elke, Delaisi, Bertrand, Delaup, Véronique, DeRicco, Adrienne, Foti, Alexia, Gan, Richard, Garriga, Laura, Gartner, Silvia, Genatossio, Alan, Grogan, Sam, Hilton, Jodi, Hoppe, Jordana E., Janssens, Hettie M., Jensen, Renee, Johnson, Robin, Kemner-van de Corput, Mariette P.C., Klein, Brendan, Lucca, Francesca, Lucidi, Vincencina, Montemitro, Enza, Nahidi, Lily, Nielsen, Kim G., Pearce, Kasey, Pittman, Jessica E., Powers, Michael, Sandvik, Rikke Mulvad, and Smith, Julie

Published
2022

30. Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study

Author

Mall, Marcus A; https://orcid.org/0000-0002-4057-2199, Brugha, Rossa, Gartner, Silvia, Legg, Julian, Moeller, Alexander, Mondejar-Lopez, Pedro, Prais, Dario, Pressler, Tacjana, Ratjen, Felix, Reix, Philippe, Robinson, Paul D, Selvadurai, Hiran, Stehling, Florian, Ahluwalia, Neil, Arteaga-Solis, Emilio, Bruinsma, Bote G, Jennings, Mark, Moskowitz, Samuel M, Noel, Sabrina, Tian, Simon, Weinstock, Tanya G, Wu, Pan, Wainwright, Claire E; https://orcid.org/0000-0001-8389-3809, Davies, Jane C, Mall, Marcus A; https://orcid.org/0000-0002-4057-2199, Brugha, Rossa, Gartner, Silvia, Legg, Julian, Moeller, Alexander, Mondejar-Lopez, Pedro, Prais, Dario, Pressler, Tacjana, Ratjen, Felix, Reix, Philippe, Robinson, Paul D, Selvadurai, Hiran, Stehling, Florian, Ahluwalia, Neil, Arteaga-Solis, Emilio, Bruinsma, Bote G, Jennings, Mark, Moskowitz, Samuel M, Noel, Sabrina, Tian, Simon, Weinstock, Tanya G, Wu, Pan, Wainwright, Claire E; https://orcid.org/0000-0001-8389-3809, and Davies, Jane C

Published
2022

31. The Management of Asymptomatic Congenital Pulmonary Airway Malformation:Results of a European Delphi Survey

Author

Kersten, Casper M., Hermelijn, Sergei M., Mullassery, Dhanya, Muthialu, Nagarajan, Cobanoglu, Nazan, Gartner, Silvia, Bagolan, Pietro, Mesas Burgos, Carmen, Sgrò, Alberto, Heyman, Stijn, Till, Holger, Suominen, Janne, Schurink, Maarten, Desender, Liesbeth, Losty, Paul, Steyaert, Henri, Terheggen-Lagro, Suzanne, Metzelder, Martin, Bonnard, Arnaud, Sfeir, Rony, Singh, Michael, Yardley, Iain, Rikkers-Mutsaerts, Noor R.V.M., van der Ent, Cornelis K., Qvist, Niels, Cox, Des W., Peters, Robert, Bannier, Michiel A.G.E., Wessel, Lucas, Proesmans, Marijke, Stanton, Michael, Hannon, Edward, Zampoli, Marco, Morini, Francesco, Tiddens, Harm A.W.M., Wijnen, René M.H., Schnater, Johannes M., Kersten, Casper M., Hermelijn, Sergei M., Mullassery, Dhanya, Muthialu, Nagarajan, Cobanoglu, Nazan, Gartner, Silvia, Bagolan, Pietro, Mesas Burgos, Carmen, Sgrò, Alberto, Heyman, Stijn, Till, Holger, Suominen, Janne, Schurink, Maarten, Desender, Liesbeth, Losty, Paul, Steyaert, Henri, Terheggen-Lagro, Suzanne, Metzelder, Martin, Bonnard, Arnaud, Sfeir, Rony, Singh, Michael, Yardley, Iain, Rikkers-Mutsaerts, Noor R.V.M., van der Ent, Cornelis K., Qvist, Niels, Cox, Des W., Peters, Robert, Bannier, Michiel A.G.E., Wessel, Lucas, Proesmans, Marijke, Stanton, Michael, Hannon, Edward, Zampoli, Marco, Morini, Francesco, Tiddens, Harm A.W.M., Wijnen, René M.H., and Schnater, Johannes M.

Abstract

Consensus on the optimal management of asymptomatic congenital pulmonary airway malformation (CPAM) is lacking, and comparison between studies remains difficult due to a large variety in outcome measures. We aimed to define a core outcome set (COS) for pediatric patients with an asymptomatic CPAM. An online, three-round Delphi survey was conducted in two stakeholder groups of specialized caregivers (surgeons and non-surgeons) in various European centers. Proposed outcome parameters were scored according to level of importance, and the final COS was established through consensus. A total of 55 participants (33 surgeons, 22 non-surgeons) from 28 centers in 13 European countries completed the three rounds and rated 43 outcome parameters. The final COS comprises seven outcome parameters: respiratory insufficiency, surgical complications, mass effect/mediastinal shift (at three time-points) and multifocal disease (at two time-points). The seven outcome parameters included in the final COS reflect the diversity in priorities among this large group of European participants. However, we recommend the incorporation of these outcome parameters in the design of future studies, as they describe measurable and validated outcomes as well as the accepted age at measurement.

Published
2022

32. The Management of Asymptomatic Congenital Pulmonary Airway Malformation: Results of a European Delphi Survey

Author

Longziekten patientenzorg, Speerpunt Child Health, Child Health, Infection & Immunity, Kersten, Casper M., Hermelijn, Sergei M., Mullassery, Dhanya, Muthialu, Nagarajan, Cobanoglu, Nazan, Gartner, Silvia, Bagolan, Pietro, Mesas Burgos, Carmen, Sgrò, Alberto, Heyman, Stijn, Till, Holger, Suominen, Janne, Schurink, Maarten, Desender, Liesbeth, Losty, Paul, Steyaert, Henri, Terheggen-Lagro, Suzanne, Metzelder, Martin, Bonnard, Arnaud, Sfeir, Rony, Singh, Michael, Yardley, Iain, Rikkers-Mutsaerts, Noor R.V.M., van der Ent, Cornelis K., Qvist, Niels, Cox, Des W., Peters, Robert, Bannier, Michiel A.G.E., Wessel, Lucas, Proesmans, Marijke, Stanton, Michael, Hannon, Edward, Zampoli, Marco, Morini, Francesco, Tiddens, Harm A.W.M., Wijnen, René M.H., Schnater, Johannes M., Longziekten patientenzorg, Speerpunt Child Health, Child Health, Infection & Immunity, Kersten, Casper M., Hermelijn, Sergei M., Mullassery, Dhanya, Muthialu, Nagarajan, Cobanoglu, Nazan, Gartner, Silvia, Bagolan, Pietro, Mesas Burgos, Carmen, Sgrò, Alberto, Heyman, Stijn, Till, Holger, Suominen, Janne, Schurink, Maarten, Desender, Liesbeth, Losty, Paul, Steyaert, Henri, Terheggen-Lagro, Suzanne, Metzelder, Martin, Bonnard, Arnaud, Sfeir, Rony, Singh, Michael, Yardley, Iain, Rikkers-Mutsaerts, Noor R.V.M., van der Ent, Cornelis K., Qvist, Niels, Cox, Des W., Peters, Robert, Bannier, Michiel A.G.E., Wessel, Lucas, Proesmans, Marijke, Stanton, Michael, Hannon, Edward, Zampoli, Marco, Morini, Francesco, Tiddens, Harm A.W.M., Wijnen, René M.H., and Schnater, Johannes M.

Published
2022

33. Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation : A Phase 3b, Randomized, Placebo-controlled Study

Author

Mall, Marcus A, Brugha, Rossa, Gartner, Silvia, Legg, Julian, Moeller, Alexander, Mondejar-Lopez, Pedro, Prais, Dario, Pressler, Tacjana, Ratjen, Felix, Reix, Philippe, Robinson, Paul D, Selvadurai, Hiran, Stehling, Florian, Ahluwalia, Neil, Arteaga-Solis, Emilio, Bruinsma, Bote G, Jennings, Mark, Moskowitz, Samuel M, Noel, Sabrina, Tian, Simon, Weinstock, Tanya G, Wu, Pan, Wainwright, Claire E, Davies, Jane C, University of Zurich, and Wainwright, Claire E

Subjects
Pulmonary and Respiratory Medicine, 10036 Medical Clinic, 2740 Pulmonary and Respiratory Medicine, Medizin, 610 Medicine & health, 2706 Critical Care and Intensive Care Medicine, Critical Care and Intensive Care Medicine
Abstract

Rationale: The triple-combination regimen elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) was shown to be safe and efficacious in children aged 6 through 11 years with cystic fibrosis and at least one F508del-CFTR allele in a phase 3, open-label, single-arm study. Objectives: To further evaluate the efficacy and safety of ELX/TEZ/IVA in children 6 through 11 years of age with cystic fibrosis heterozygous for F508del and a minimal function CFTR mutation (F/MF genotypes) in a randomized, double-blind, placebo-controlled phase 3b trial. Methods: Children were randomized to receive either ELX/TEZ/IVA (n = 60) or placebo (n = 61) during a 24-week treatment period. The dose of ELX/TEZ/IVA administered was based on weight at screening, with children,30 kg receiving ELX 100 mg once daily, TEZ 50 mg once daily, and IVA 75 mg every 12 hours, and children >30 kg receiving ELX 200 mg once daily, TEZ 100 mg once daily, and IVA 150 mg every 12 hours (adult dose). Measurements and Main Results: The primary endpoint was absolute change in lung clearance index₂.₅ from baseline through Week 24. Children given ELX/TEZ/IVA had a mean decrease in lung clearance index₂.₅ of 2.29 units (95% confidence interval [CI], 1.97–2.60) compared with 0.02 units (95% CI, 20.29 to 0.34) in children given placebo (between-group treatment difference, 22.26 units; 95% CI, 22.71 to 21.81; P, 0.0001). ELX/TEZ/IVA treatment also led to improvements in the secondary endpoint of sweat chloride concentration (between-group treatment difference, 251.2 mmol/L; 95% CI, 255.3 to 247.1) and in the other endpoints of percent predicted FEV₁ (between-group treatment difference, 11.0 percentage points; 95% CI, 6.9–15.1) and Cystic Fibrosis Questionnaire-Revised Respiratory domain score (between-group treatment difference, 5.5 points; 95% CI, 1.0–10.0) compared with placebo from baseline through Week 24. The most common adverse events in children receiving ELX/TEZ/IVA were headache and cough (30.0% and 23.3%, respectively); most adverse events were mild or moderate in severity. Conclusions: In this first randomized, controlled study of a cystic fibrosis transmembrane conductance regulator modulator conducted in children 6 through 11 years of age with F/MF genotypes, ELX/TEZ/IVA treatment led to significant improvements in lung function, as well as robust improvements in respiratory symptoms and cystic fibrosis transmembrane conductance regulator function. ELX/TEZ/IVA was generally safe and well tolerated in this pediatric population with no new safety findings.

Published
2022

35. European best practice guidelines for cystic fibrosis neonatal screening

Author

Castellani, Carlo, Southern, Kevin W., Brownlee, Keith, Dankert Roelse, Jeannette, Duff, Alistair, Farrell, Michael, Mehta, Anil, Munck, Anne, Pollitt, Rodney, Sermet-Gaudelus, Isabelle, Wilcken, Bridget, Ballmann, Manfred, Corbetta, Carlo, de Monestrol, Isabelle, Farrell, Philip, Feilcke, Maria, Férec, Claude, Gartner, Silvia, Gaskin, Kevin, Hammermann, Jutta, Kashirskaya, Nataliya, Loeber, Gerard, Macek, Milan, Jr., Mehta, Gita, Reiman, Andreas, Rizzotti, Paolo, Sammon, Alec, Sands, Dorota, Smyth, Alan, Sommerburg, Olaf, Torresani, Toni, Travert, Georges, Vernooij, Annette, and Elborn, Stuart

Published
2009
Full Text
View/download PDF

36. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

Author

Bell, Scott C, Reid, David, Wark, Peter, Braeckel, Eva Van, Gohy, Sophie, Knoop, Christiane, Pirson, Jessica, Wachter, Elke De, Dupont, Lieven, Hanssens, Laurence, Nowé, Vicky, Lequesne, Monique, Athanazio, Rodrigo A, Meneses, Daniela G, Boussaud, Véronique, Brinchault, Graziella, Coirier-Duet, Emmanuelle, Dubus, Jean-Christophe, Grenet, Dominique, Miranda, Sandra de, Beaumont, Laurence, Kanaan, Reem, Lauraens, Muriel, Martin, Clémence, Martin, Marie Mittaine, Prévotat, Anne, Reynaud-Gaubert, Martine, Sermet-Gaudelus, Isabelle, Tatopoulos, Aurelie, Chiron, Raphael, Dalphin, Marie-Laure, Gerardin, Michele, Weiss, Laurence, Wizla, Nathalie, Ramel, Sophie, Plant, Barry, Gunaratnam, Cedric, Jackson, Abaigeal, Casciaro, Rosaria, Lucca, Francesca, Daccò, Valeria, Folino, Anna, Manca, Antonio, Messore, Barbara, Morlacchi, Letizia, Pisi, Giovanna, Poli, Piercarlo, Amato, Annalisa, Ferrari, Gianluca, de Winter- de Groot, Karin, Luijk, Bart, Wesseling, Geertjan, Kondratyeva, Elena, Zhekayte, Elena, Amelina, Elena, Mukhina, Mariya, Simonova, Olga, Alvarez-Fernandez, Antonio, Sole-Jover, Amparo, Cortell-Aznar, Isidoro, Giron-Moreno, Rosa, Lopez-Neyra, Alejandro, Ramos-Cancelo, Isabel, Lzaro-Carrasco, Maite, Ruiz de Valbuena, Marta, Prados-Sanchez, Concepcin, Costa-Colomer, Jordi, Gartner, Silvia, Diab-Caceres, Layla, Gilljam, Marita, Lindberg, Ulrika, Diemer, Stefanie, Allenby, Mark, J Bourke, Stephen, C Charman, Susan, Collinson, Janet, Dempsey, Owen, Denniston, Sarah, Desai, Maya, Duckers, Jamie, Etherington, Christine, Gunn, Elaine, Higton, Alex, Ho, Timothy, Hull, Jeremy, Jones, Andrew, Ian Ketchell, Robert, Madge, Susan L., Maitra, Anirban, Mujtaba, Ghulam, Nash, Edward, Nazareth, Dilip, OBrien, Christopher, Onyon, Claire, Orchard, Christopher, Peckham, Daniel, Rodgers, Helen, Shafi, Nadia, Simmonds, Nicholas, Southern, Kevin, Walshaw, Martin, Watson, Danie, L Whitehouse, Joanna, McClenaghan, Elliot, Cosgriff, Rebecca, Brownlee, Keith, Ahern, Susannah, Burgel, Pierre-Régis, Byrnes, Catherine A, Colombo, Carla, Corvol, Harriet, Cheng, Stephanie Y, Daneau, Géraldine, Elbert, Alexander, Faro, Albert, Goss, Christopher H, Gulmans, Vincent, Gutierrez, Hector, de Monestrol, Isabelle, Jung, Andreas, Justus, Lutz Nährlich, Kashirskaya, Nataliya, Marshall, Bruce C, McKone, Edward, Middleton, Peter G, Mondejar-Lopez, Pedro, Pastor-Vivero, M Dolores, Padoan, Rita, Rizvi, Samar, Ruseckaite, Rasa, Salvatore, Marco, Stephenson, Anne L., Filho, Luiz Vicente R da Silva, Melo, Joel, Zampoli, Marco, and Carr, Siobhán B

Published
2020
Full Text
View/download PDF

38. Development of a core outcome set for congenital pulmonary airway malformations: study protocol of an international Delphi survey

Author

Hermelijn, Sergei, Kersten, Casper, Mullassery, Dhanya, Muthialu, Nagarajan, Cobanoglu, Nazan, Gartner, Silvia, Schurink, M., Wijnen, R.M.H., Schnater, Marco, Hermelijn, Sergei, Kersten, Casper, Mullassery, Dhanya, Muthialu, Nagarajan, Cobanoglu, Nazan, Gartner, Silvia, Schurink, M., Wijnen, R.M.H., and Schnater, Marco

Abstract

Contains fulltext : 233479.pdf (Publisher’s version ) (Open Access)

Published
2021

39. Development of a core outcome set for congenital pulmonary airway malformations: study protocol of an international Delphi survey

Author

Hermelijn, Sergei, primary, Kersten, Casper, additional, Mullassery, Dhanya, additional, Muthialu, Nagarajan, additional, Cobanoglu, Nazan, additional, Gartner, Silvia, additional, Bagolan, Pietro, additional, Mesas Burgos, Carmen, additional, Sgro, Alberto, additional, Heyman, Stijn, additional, Till, Holger, additional, Suominen, Janne, additional, Schurink, Maarten, additional, Desender, Liesbeth, additional, Losty, Paul, additional, Ertresvag, Kjetil, additional, Tiddens, Harm A W M, additional, Wijnen, Rene M H, additional, and Schnater, Marco, additional

Published
2021
Full Text
View/download PDF

40. Immunofluorescence Analysis as a Diagnostic Tool in a Spanish Cohort of Patients with Suspected Primary Ciliary Dyskinesia

Author

Baz-Redón, Noelia, primary, Rovira-Amigo, Sandra, additional, Fernández-Cancio, Mónica, additional, Castillo-Corullón, Silvia, additional, Cols, Maria, additional, Caballero-Rabasco, M. Araceli, additional, Asensio, Óscar, additional, Martín de Vicente, Carlos, additional, Martínez-Colls, Maria del Mar, additional, Torrent-Vernetta, Alba, additional, de Mir-Messa, Inés, additional, Gartner, Silvia, additional, Iglesias-Serrano, Ignacio, additional, Díez-Izquierdo, Ana, additional, Polverino, Eva, additional, Amengual-Pieras, Esther, additional, Amaro-Rodríguez, Rosanel, additional, Vendrell, Montserrat, additional, Mumany, Marta, additional, Pascual-Sánchez, María Teresa, additional, Pérez-Dueñas, Belén, additional, Reula, Ana, additional, Escribano, Amparo, additional, Dasí, Francisco, additional, Armengot-Carceller, Miguel, additional, Garrido-Pontnou, Marta, additional, Camats-Tarruella, Núria, additional, and Moreno-Galdó, Antonio, additional

Published
2020
Full Text
View/download PDF

41. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

Author

McClenaghan, Elliot, primary, Cosgriff, Rebecca, additional, Brownlee, Keith, additional, Ahern, Susannah, additional, Burgel, Pierre-Régis, additional, Byrnes, Catherine A, additional, Colombo, Carla, additional, Corvol, Harriet, additional, Cheng, Stephanie Y, additional, Daneau, Géraldine, additional, Elbert, Alexander, additional, Faro, Albert, additional, Goss, Christopher H, additional, Gulmans, Vincent, additional, Gutierrez, Hector, additional, de Monestrol, Isabelle, additional, Jung, Andreas, additional, Justus, Lutz Nährlich, additional, Kashirskaya, Nataliya, additional, Marshall, Bruce C, additional, McKone, Edward, additional, Middleton, Peter G, additional, Mondejar-Lopez, Pedro, additional, Pastor-Vivero, M Dolores, additional, Padoan, Rita, additional, Rizvi, Samar, additional, Ruseckaite, Rasa, additional, Salvatore, Marco, additional, Stephenson, Anne L., additional, Filho, Luiz Vicente R da Silva, additional, Melo, Joel, additional, Zampoli, Marco, additional, Carr, Siobhán B, additional, Bell, Scott C, additional, Reid, David, additional, Wark, Peter, additional, Braeckel, Eva Van, additional, Gohy, Sophie, additional, Knoop, Christiane, additional, Pirson, Jessica, additional, Wachter, Elke De, additional, Dupont, Lieven, additional, Hanssens, Laurence, additional, Nowé, Vicky, additional, Lequesne, Monique, additional, Athanazio, Rodrigo A, additional, Meneses, Daniela G, additional, Boussaud, Véronique, additional, Brinchault, Graziella, additional, Coirier-Duet, Emmanuelle, additional, Dubus, Jean-Christophe, additional, Grenet, Dominique, additional, Miranda, Sandra de, additional, Beaumont, Laurence, additional, Kanaan, Reem, additional, Lauraens, Muriel, additional, Martin, Clémence, additional, Martin, Marie Mittaine, additional, Prévotat, Anne, additional, Reynaud-Gaubert, Martine, additional, Sermet-Gaudelus, Isabelle, additional, Tatopoulos, Aurelie, additional, Chiron, Raphael, additional, Dalphin, Marie-Laure, additional, Gerardin, Michele, additional, Weiss, Laurence, additional, Wizla, Nathalie, additional, Ramel, Sophie, additional, Plant, Barry, additional, Gunaratnam, Cedric, additional, Jackson, Abaigeal, additional, Casciaro, Rosaria, additional, Lucca, Francesca, additional, Daccò, Valeria, additional, Folino, Anna, additional, Manca, Antonio, additional, Messore, Barbara, additional, Morlacchi, Letizia, additional, Pisi, Giovanna, additional, Poli, Piercarlo, additional, Amato, Annalisa, additional, Ferrari, Gianluca, additional, de Winter- de Groot, Karin, additional, Luijk, Bart, additional, Wesseling, Geertjan, additional, Kondratyeva, Elena, additional, Zhekayte, Elena, additional, Amelina, Elena, additional, Mukhina, Mariya, additional, Simonova, Olga, additional, Alvarez-Fernandez, Antonio, additional, Sole-Jover, Amparo, additional, Cortell-Aznar, Isidoro, additional, Giron-Moreno, Rosa, additional, Lopez-Neyra, Alejandro, additional, Ramos-Cancelo, Isabel, additional, Lzaro-Carrasco, Maite, additional, Ruiz de Valbuena, Marta, additional, Prados-Sanchez, Concepcin, additional, Costa-Colomer, Jordi, additional, Gartner, Silvia, additional, Diab-Caceres, Layla, additional, Gilljam, Marita, additional, Lindberg, Ulrika, additional, Diemer, Stefanie, additional, Allenby, Mark, additional, J Bourke, Stephen, additional, C Charman, Susan, additional, Collinson, Janet, additional, Dempsey, Owen, additional, Denniston, Sarah, additional, Desai, Maya, additional, Duckers, Jamie, additional, Etherington, Christine, additional, Gunn, Elaine, additional, Higton, Alex, additional, Ho, Timothy, additional, Hull, Jeremy, additional, Jones, Andrew, additional, Ian Ketchell, Robert, additional, Madge, Susan L., additional, Maitra, Anirban, additional, Mujtaba, Ghulam, additional, Nash, Edward, additional, Nazareth, Dilip, additional, OBrien, Christopher, additional, Onyon, Claire, additional, Orchard, Christopher, additional, Peckham, Daniel, additional, Rodgers, Helen, additional, Shafi, Nadia, additional, Simmonds, Nicholas, additional, Southern, Kevin, additional, Walshaw, Martin, additional, Watson, Danie, additional, and L Whitehouse, Joanna, additional

Published
2020
Full Text
View/download PDF

42. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

Author

Mondejar-Lopez, Pedro, primary, Quintana-Gallego, Esther, additional, Giron-Moreno, Rosa M., additional, Cortell-Aznar, Isidoro, additional, Ruiz de Valbuena-Maiz, Marta, additional, Diab-Caceres, Layla, additional, Prados-Sanchez, Concepcion, additional, Alvarez-Fernandez, Antonio, additional, Garcia-Marcos, Patricia W., additional, Peñalver-Mellado, Carlos, additional, Pastor-Vivero, M. Dolores, additional, Olveira, Casilda, additional, Lopez-Neyra, Alejandro, additional, Castillo-Corullon, Silvia, additional, Palma-Milla, Samara, additional, Perez-Ruiz, Estela, additional, Sole-Jover, Amparo, additional, Barrio, M. Isabel, additional, Sanchez-Solis, Manuel, additional, Asensio de la Cruz, Óscar, additional, Aguilar-Fernández, Antonio J., additional, Andres-Martin, Anselmo, additional, Blanco-Aparicio, Marina, additional, Sirvent-Gomez, Josep, additional, Barajas-Sanchez, Verisima, additional, Baranda, Felix, additional, Gomez-Bonilla, Ainhoa, additional, Bousoño-Garcia, Carlos, additional, Garcia-Clemente, Marta, additional, Bover-Bauza, Catalina, additional, Figuerola-Mulet, Joan, additional, Cabero-Perez, M. Jesús, additional, Iturbe-Fernandez, David, additional, Carrasco-Hernandez, Laura, additional, Delgado-Pecellin, Isabel, additional, Casas-Maldonado, Francisco, additional, Merlos-Navarro, Silvia, additional, Valenzuela-Soria, Alfredo, additional, Cascante-Rodrigo, J. Antonio, additional, Moreno-Galarraga, Laura, additional, Cols-Roig, Maria, additional, de la Cruz, Ofelia Fernandez, additional, Gomez de Terreros, Francisco J., additional, Garcia-Magan, Carlos, additional, Gartner, Silvia, additional, Gomez-Pastrana, David, additional, Gonzalez-Castro, Estela, additional, Jimenez-Nogueira, Esperanza, additional, Herrero-Labarga, M. Ines, additional, de Vicente, Carlos Martín, additional, Juste-Ruiz, Mercedes, additional, Lamas-Ferreiro, Adelaida, additional, Maiz-Carro, Luis, additional, Luna-Paredes, M. Carmen, additional, Mesa-Medina, Orlando, additional, Monton-Soler, Concepcion, additional, Ramos-Hernandez, Cristina, additional, Rodriguez-Saez, M. Jesus, additional, Romero-Albillos, J. Alejandro, additional, Sanz-Santiago, Veronica, additional, Villa-Asensi, J. Ramón, additional, Torres-Borrego, Javier, additional, Vaquero-Barrios, J. Manuel, additional, Velasco-Bernardo, Rosa, additional, and Velasco-Gonzalez, Valle, additional

Published
2020
Full Text
View/download PDF

43. Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis

Author

Bilton, Diana, primary, Pressler, Tacjana, additional, Fajac, Isabelle, additional, Clancy, John Paul, additional, Sands, Dorota, additional, Minic, Predrag, additional, Cipolli, Marco, additional, Galeva, Ivanka, additional, Solé, Amparo, additional, Quittner, Alexandra L., additional, Liu, Keith, additional, McGinnis, John P., additional, Eagle, Gina, additional, Gupta, Renu, additional, Konstan, Michael W., additional, Renner, Sabine, additional, Knoop, Christiane, additional, Malfroot, Anne, additional, Dupont, Lieven, additional, Desager, Kristine, additional, De Baets, Frans, additional, Bosheva, Miroslava, additional, Nedkova, Vania, additional, Galabov, Ivan, additional, Freitag, Andreas, additional, Morrison, Nancy, additional, Wilcox, Pearce, additional, Pressler, Tanja, additional, Martinet, Yves, additional, Chiron, Raphael, additional, Dominique, Stephan, additional, Reix, Philippe, additional, Prevotat, Anne, additional, Sermet, Isabelle, additional, Durieu, Isabelle, additional, Fischer, Rainald, additional, Huber, Rudolf, additional, Staab, Doris, additional, Mellies, Uwe, additional, Sextro, Wolfgang, additional, Welte, Tobias, additional, Wilkens, Heinrike, additional, Sommerwerk, Urte, additional, Bewig, Burkhard, additional, Inglezos, Ilias, additional, Doudounakis, Stavros-Eleftherios, additional, Bede, Olga, additional, Gönczi, Ferenc, additional, Újhelyi, Rita, additional, McKone, Edward, additional, McNally, Paul, additional, Lucidi, Vincenzina, additional, La Rosa, Mario, additional, Minicucci, Laura, additional, Padoan, Rita, additional, Pisi, Giovanna, additional, Gagliardini, Rolando, additional, Colombo, Carla, additional, Bronsveld, Inez, additional, Sapiejka, Ewa, additional, Mazurek, Henryk, additional, Górnicka, Grażyna, additional, Stelmach, Iwona, additional, Batura-Gabryel, Halina, additional, Rachel, Marta, additional, Orosova, Jaroslava, additional, Takac, Branko, additional, Feketova, Anna, additional, Martinez, Carmen, additional, Hernandez, Gloria Garcia, additional, Villa-Asensi, Jose Ramon, additional, Gartner, Silvia, additional, Sole, Amparo, additional, Lindblad, Anders, additional, Ledson, Martin, additional, Bilton, Diana, additional, Whitehouse, Joanna, additional, Smyth, Alan, additional, Ketchell, Ian, additional, Lee, Timothy, additional, and MacGregor, Gordon, additional

Published
2020
Full Text
View/download PDF

44. Impact of COVID-19 on people with cystic fibrosis

Author

Colombo, Carla, Burgel, Pierre-Regis, Gartner, Silvia, van Koningsbruggen-Rietschel, Silke, Naehrlich, Lutz, Sermet-Gaudelus, Isabelle, Southern, Kevin W., Colombo, Carla, Burgel, Pierre-Regis, Gartner, Silvia, van Koningsbruggen-Rietschel, Silke, Naehrlich, Lutz, Sermet-Gaudelus, Isabelle, and Southern, Kevin W.

Published
2020

45. Immunofluorescence Analysis as a Diagnostic Tool in a Spanish Cohort of Patients with Suspected Primary Ciliary Dyskinesia

Author

Baz-Redón, Noelia, Rovira-Amigo, Sandra, Fernández Cancio, Mónica, Castillo-Corullón, Silvia, Cols, Maria, Caballero-Rabasco, M. Araceli, Asensio, Óscar, Martín de Vicente, Carlos, Martínez-Colls, Maria del Mar, Torrent-Vernetta, Alba, de Mir-Messa, Inés, Gartner, Silvia, Iglesias-Serrano, Ignacio, Díez-Izquierdo, Ana, Polverino, Eva, Amengual-Pieras, Esther, Amaro-Rodríguez, Rosanel, Vendrell, Montserrat, Mumany, Marta, Pascual-Sánchez, María Teresa, Pérez-Dueñas, Belén, Reula, Ana, Escribano, Amparo, Dasí, Francisco, Armengot-Carceller, Miguel, Garrido-Pontnou, Marta, Camats Tarruella, Núria, Moreno Galdó, Antonio, Universitat Autònoma de Barcelona, Baz-Redón, Noelia, Rovira-Amigo, Sandra, Fernández Cancio, Mónica, Castillo-Corullón, Silvia, Cols, Maria, Caballero-Rabasco, M. Araceli, Asensio, Óscar, Martín de Vicente, Carlos, Martínez-Colls, Maria del Mar, Torrent-Vernetta, Alba, de Mir-Messa, Inés, Gartner, Silvia, Iglesias-Serrano, Ignacio, Díez-Izquierdo, Ana, Polverino, Eva, Amengual-Pieras, Esther, Amaro-Rodríguez, Rosanel, Vendrell, Montserrat, Mumany, Marta, Pascual-Sánchez, María Teresa, Pérez-Dueñas, Belén, Reula, Ana, Escribano, Amparo, Dasí, Francisco, Armengot-Carceller, Miguel, Garrido-Pontnou, Marta, Camats Tarruella, Núria, Moreno Galdó, Antonio, and Universitat Autònoma de Barcelona

Abstract

Primary ciliary dyskinesia (PCD) is an autosomal recessive rare disease caused by an alteration of ciliary structure. Immunofluorescence, consisting in the detection of the presence and distribution of cilia proteins in human respiratory cells by fluorescence, has been recently proposed as a technique to improve understanding of disease-causing genes and diagnosis rate in PCD. The objective of this study is to determine the accuracy of a panel of four fluorescently labeled antibodies (DNAH5, DNALI1, GAS8 and RSPH4A or RSPH9) as a PCD diagnostic tool in the absence of transmission electron microscopy analysis. The panel was tested in nasal brushing samples of 74 patients with clinical suspicion of PCD. Sixty-eight (91.9%) patients were evaluable for all tested antibodies. Thirty-three cases (44.6%) presented an absence or mislocation of protein in the ciliary axoneme (15 absent and 3 proximal distribution of DNAH5 in the ciliary axoneme, 3 absent DNAH5 and DNALI1, 7 absent DNALI1 and cytoplasmatic localization of GAS8, 1 absent GAS8, 3 absent RSPH9 and 1 absent RSPH4A). Fifteen patients had confirmed or highly likely PCD but normal immunofluorescence results (68.8% sensitivity and 100% specificity). In conclusion, immunofluorescence analysis is a quick, available, low-cost and reliable diagnostic test for PCD, althouh it cannot be used as a standalone test

Published
2020

46. 50 años del programa de cribado neonatal en Cataluña

Author

Marín Soria, José Luis, López Galera, Rosa María, Argudo Ramírez, Ana, González de Aledo Castillo, Jose Manuel, Pajares García, Sonia, Navarro Sastre, Aleix, Hernandez Pérez, Jose Mª, Mogas Viñals, Eduardo, Giralt Arnaiz, Marina, Campistol Plana, Jaume, Blanco Álvarez, Adoración, Murillo Sanjuán, Laura, García Volpe, C., Parra Martínez, Alba, Asensio de la Cruz, Óscar, Yeste Fernández, Diego, Clemente León, María, García Cazorla, Ángels, Beneitez Pastor, David, Roué, Gaël, Velasco Puyó, Pablo, Mañú Pereira, María del Mar, Toro Riera, M. del, Ferrer, R., de los Santos Mercedes, M., Ruiz Hernández, Carlos José, Soler Palacín, Pere, Vidal Benede, Mª José, Fernández Bardon, Rosa Mª, Asso Ministral, Laia, Cabezas Peña, Carmen, Ribes Rubió, Antònia, Gort Mas, Laura, García Villoria, Judit, Gartner, Silvia, Rovira Amigo, Sandra, García González, Miguel, Cols Roig, María, Costa Colomer, Jordi, Badenas, Cèlia, Campos Martorell, Ariadna, Ortuño Cabrero, Ana, Tazón, Barbara, Murciano, Thais, Díaz de Heredia Rubio, C., Vives Corrons, Joan Lluís, Arranz, José Antonio, Carnicer Cáceres, Clara, Ormazabal Herrero, Aida, Artuch Iriberri, Rafael, Rivière, Jacques G., Martínez Gallo, Mònica, Prats, Blanca, Armelles Sebastia, Mercedes, Jané Checa, Mireia, Sierra March, Cristina, Meavilla Olivas, S., Martín Nalda, Andrea, Colobran Oriol, Roger, Casals Senent, Teresa, Marín Soria, José Luis, López Galera, Rosa María, Argudo Ramírez, Ana, González de Aledo Castillo, Jose Manuel, Pajares García, Sonia, Navarro Sastre, Aleix, Hernandez Pérez, Jose Mª, Mogas Viñals, Eduardo, Giralt Arnaiz, Marina, Campistol Plana, Jaume, Blanco Álvarez, Adoración, Murillo Sanjuán, Laura, García Volpe, C., Parra Martínez, Alba, Asensio de la Cruz, Óscar, Yeste Fernández, Diego, Clemente León, María, García Cazorla, Ángels, Beneitez Pastor, David, Roué, Gaël, Velasco Puyó, Pablo, Mañú Pereira, María del Mar, Toro Riera, M. del, Ferrer, R., de los Santos Mercedes, M., Ruiz Hernández, Carlos José, Soler Palacín, Pere, Vidal Benede, Mª José, Fernández Bardon, Rosa Mª, Asso Ministral, Laia, Cabezas Peña, Carmen, Ribes Rubió, Antònia, Gort Mas, Laura, García Villoria, Judit, Gartner, Silvia, Rovira Amigo, Sandra, García González, Miguel, Cols Roig, María, Costa Colomer, Jordi, Badenas, Cèlia, Campos Martorell, Ariadna, Ortuño Cabrero, Ana, Tazón, Barbara, Murciano, Thais, Díaz de Heredia Rubio, C., Vives Corrons, Joan Lluís, Arranz, José Antonio, Carnicer Cáceres, Clara, Ormazabal Herrero, Aida, Artuch Iriberri, Rafael, Rivière, Jacques G., Martínez Gallo, Mònica, Prats, Blanca, Armelles Sebastia, Mercedes, Jané Checa, Mireia, Sierra March, Cristina, Meavilla Olivas, S., Martín Nalda, Andrea, Colobran Oriol, Roger, and Casals Senent, Teresa

Abstract

The Catalonian Newborn Screening Program (CNSP) began in 1969, in Barcelona. It was promoted by Dr. Juan Sabater Tobella and supported by Barcelona Provincial Council and Juan March Foundation. That is how the Institute of Clinical Biochemistry was born, whose aims were diagnosis, research and teaching, along with the spirit of contributing to the prevention of mental retardation. The CNSP began with the detection of phenylketonuria (PKU), and, in 1982, the Program was expanded with the inclusion of congenital hypothyroidism detection. Towards 1990, the Program covered almost 100% of all newborns (NB) in Catalonia. In 1999, the CNSP was expanded with the incorporation of cystic fibrosis. It took fourteen years, until 2013, to make the largest expansion so far, with the incorporation of 19 metabolic diseases to the screening panel. The detection of sickle cell disease began in 2015 and in 2017 the detection of severe combined immunodeficiency was included. Currently, the CNSP includes 24 diseases in its main panel. Since 1969, 2,787,807 NBs have been screened, of whom 1,724 have been diagnosed with any of these diseases, and 252 of other disorders by differential diagnosis with those included in the main panel. The global prevalence is 1: 1,617 NBs affected by any of the diseases included in the CNSP and 1: 1,140 NBs if incidental findings diagnosed through the CNSP are included., El Programa de Cribado Neonatal de Cataluña (PCNC) se inició en el año 1969, en Barcelona, impulsado por el Dr. Juan Sabater Tobella y apoyado por la Diputación de Barcelona y la Fundación Juan March. Así nació el Instituto de Bioquímica Clínica para acometer funciones asistenciales, de investigación y docencia, con el espíritu de contribuir a la prevención del retraso mental. El PCNC se inició con la detección de la fenilcetonuria (PKU) y en el año 1982 se amplió con la detección del hipotiroidismo congénito. Hacia el año 1990 la cobertura territorial llegó casi al 100% de todos los recién nacidos en Cataluña. En 1999 se amplió el PCNC con la incorporación de la fibrosis quística y tras catorce años, en 2013, se realizó la ampliación más numerosa hasta ahora, con la incorporación de la detección de 19 enfermedades metabólicas hereditarias. En el año 2015 comenzó la detección de la enfermedad de células falciformes y en el 2017 la detección de la inmunodeficiencia combinada grave. Actualmente, el PCNC incluye la detección de 24 enfermedades. Desde su inicio en el año 1969, se han cribado 2.787.807 recién nacidos, de los cuales 1.724 han sido diagnosticados de alguna de las 24 enfermedades que componen nuestro panel principal y 252 por diagnóstico diferencial de las primeras. En total la prevalencia global es de 1:1.617 RN afectos de alguna de las enfermedades incluidas en el PCNC y de 1:1.140 RN si se incluyen los hallazgos incidentales encontrados.

Published
2020

47. Cystic fibrosis patients with the 3272-26A>G splicing mutation have milder disease than F508del homozygotes: a large European study

Author

Amaral, Margarida D, Pacheco, Paula, Beck, Sebastian, Farinha, Carlos M, Penque, Deborah, Nogueira, Paulo, Barreto, Celeste, Lopes, Beatriz, Casals, Teresa, Dapena, Javier, Gartner, Silvia, Vásquez, Carlos, Pérez-Frías, Javier, Olveira, Casilda, Cabanas, Rodrigo, Estivill, Xavier, Tzetis, Maria, Kanavakis, Emmanuel, Doudounakis, Stavros, Dörk, Thilo, Tümmler, Burkhard, Girodon-Boulandet, Emmanuelle, Cazeneuve, Cécile, Goossens, Michel, Blayau, Martine, Verlingue, Claudine, Vieira, Isabel, Féréc, Claude, Claustres, Mireille, Georges, Marie des, Clavel, Christine, Birembaut, Philippe, Hubert, Dominique, Bienvenu, Thierry, Adoun, Michèle, Chomel, Jean-Claude, De Boeck, Kris, Cuppens, Harry, and Lavinha, João

Published
2001

48. Detection of Bacteriophage Particles Containing Antibiotic Resistance Genes in the Sputum of Cystic Fibrosis Patients

Author

Brown-Jaque, Maryury, Rodriguez Oyarzun, Lirain, Cornejo-Sánchez, Thais, Martín-Gómez, Maria T., Gartner, Silvia, de Gracia, Javier, Rovira, Sandra, Alvarez, Antonio, Jofre, Joan, González-López, Juan J., Muniesa, Maite, and Universitat de Barcelona

Subjects
bacteriophages, lcsh:QR1-502, sputum, Fibrosi quística, Microbiology, Bacteriòfags, Cystic fibrosis, lcsh:Microbiology, cystic fibrosis, antibiotic resistance genes, Drug resistance, horizontal gene transfer, Bacteriophages, Original Research, Resistència als medicaments
Abstract

Cystic fibrosis (CF) is a chronic disease in which the bacterial colonization of the lung is linked to an excessive inflammatory response that leads to respiratory failure. The microbiology of CF is complex. Staphylococcus aureus is the first bacterium to colonize the lungs in 30% of pediatric CF patients, and 80% of adult patients develop a chronic Pseudomonas aeruginosa infection, but other microorganisms can also be found. The use of antibiotics is essential to treat the disease, but antibiotic performance is compromised by resistance mechanisms. Among various mechanisms of transfer of antibiotic resistance genes (ARGs), the recently been reported bacteriophages are the least explored in clinical settings. To determine the role of phages in CF as mobile genetic elements (MGEs) carrying ARGs, we evaluated their presence in 71 CF patients. 71 sputum samples taken from these patients were screened for eight ARGs (blaTEM, blaCTX-M-1-group, blaCTX-M-9-group, blaOXA-48, blaVIM, mecA, qnrA, and qnrS) in the bacteriophage DNA fraction. The phages found were also purified and observed by electron microscopy. 32.4% of CF patients harbored ARGs in phage DNA. β-lactamase genes, particularly blaVIM and blaTEM, were the most prevalent and abundant, whereas mecA, qnrA, and qnrS were very rare. Siphoviridae phage particles capable of infecting P. aeruginosa and Klebsiella pneumoniae were detected in CF sputum. Phage particles harboring ARGs were found to be abundant in the lungs of both CF patients and healthy individuals and could contribute to the colonization of multiresistant strains.

Published
2018
Full Text
View/download PDF

49. The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids : a basis for read-through therapies in cystic fibrosis

Author

Clarke, Luka A., Awatade, Nikhil T., Felício, Veronica M., Silva, Iris A., Calucho, Maite, Pereira, Luisa, Azevedo, Pilar, Cavaco, José, Barreto, Celeste, Bertuzzo, Carmen, Gartner, Silvia, Beekman, Jeffrey, Amaral, Margarida D., Clarke, Luka A., Awatade, Nikhil T., Felício, Veronica M., Silva, Iris A., Calucho, Maite, Pereira, Luisa, Azevedo, Pilar, Cavaco, José, Barreto, Celeste, Bertuzzo, Carmen, Gartner, Silvia, Beekman, Jeffrey, and Amaral, Margarida D.

Published
2019

50. The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read-through therapies in cystic fibrosis

Author

dLAB Biobank, Onderzoek, Longziekten onderzoek 2, Child Health, Regenerative Medicine and Stem Cells, Clarke, Luka A., Awatade, Nikhil T., Felício, Veronica M., Silva, Iris A., Calucho, Maite, Pereira, Luisa, Azevedo, Pilar, Cavaco, José, Barreto, Celeste, Bertuzzo, Carmen, Gartner, Silvia, Beekman, Jeffrey, Amaral, Margarida D., dLAB Biobank, Onderzoek, Longziekten onderzoek 2, Child Health, Regenerative Medicine and Stem Cells, Clarke, Luka A., Awatade, Nikhil T., Felício, Veronica M., Silva, Iris A., Calucho, Maite, Pereira, Luisa, Azevedo, Pilar, Cavaco, José, Barreto, Celeste, Bertuzzo, Carmen, Gartner, Silvia, Beekman, Jeffrey, and Amaral, Margarida D.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results